89. リンパ脈管筋腫症 Lymphangioleiomyomatosis Clinical trials / Disease details
臨床試験数 : 39 / 薬物数 : 46 - (DrugBank : 20) / 標的遺伝子数 : 27 - 標的パスウェイ数 : 137
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01799538 (ClinicalTrials.gov) | June 10, 2013 | 23/2/2013 | Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis | Bronchodilator Effects of Nebulized Versus Inhaled Albuterol in Subjects With Lymphangioleiomyomatosis | Lymphangioleiomyomatosis | Drug: albuterol inhaler;Drug: albuterol nebulizer;Procedure: PFT | National Heart, Lung, and Blood Institute (NHLBI) | NULL | Recruiting | 18 Years | N/A | Female | 100 | Phase 1/Phase 2 | United States |